Efficacy of Adding Bortezomib to Salvage Chemotherapy in Relapsed/refractory Acute Myeloid Leukemia a Prospective Non-Interventional Study

Relapsed/refractory acute myeloid leukemia (RR-AML) are important types of hematological malignancy for which no effective salvage chemotherapy has been approved. The main purpose of this study was to determine the effectiveness of adding Bortezomib to salvage chemotherapy protocol in RR-AML patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Ghadiany, Mojtaba, Tabarraei, Mehdi, Varaminian, Beehnaz, Salari, Sina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842590/
https://www.ncbi.nlm.nih.gov/pubmed/35194425
http://dx.doi.org/10.22037/ijpr.2021.115475.15409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8842590/
https://www.ncbi.nlm.nih.gov/pubmed/35194425
http://dx.doi.org/10.22037/ijpr.2021.115475.15409

Ejemplares similares